Be the first to like this
This report profiles 18 of the largest and fastest growing domestic Chinese pharmaceutical companies by examining their corporate structure, current products, therapeutic areas of focus, R&D efforts, and financial performance.
Whether your organization (or department) views domestic Chinese pharmaceutical companies as a competitor, complementor, or as a catalyst, they are becoming an increasing force in the global healthcare industry. While it is not easy to get summarized company-specific information on domestic Chinese pharmaceutical companies, ISR has done the legwork for you. In this report we profile 18 of the largest and fastest growing domestic Chinese pharmaceutical companies. We profile their corporate structure, current products, therapeutic areas of focus, R&D efforts, and financial performance. We think you’ll find this report to be a superior source of information on some of China’s largest and fastest growing pharmaceutical companies.
The companies profiled in this report accounted for nearly $15billion USD in revenue in 2010 and over $1.2billion USD in net income.
Companies Profiled: 3SBio
American Oriental Bioengineering
Beijing Double-crane Pharmaceutical Company
China Buchang Pharmaceutical Group
China Resources Sanjiu Medical & Pharmaceutical Company
Guangzhou Pharmaceutical Holdings
Harbin Pharmaceutical Group
North China Pharmaceutical Group
Qilu Pharmaceutical Company
Shandong Xinhua Pharmaceutical Company
Shanghai Fosun Pharmaceutical Group
Shanghai Pharmaceutical Group
Simcere Pharmaceutical Group
Yangtze River Pharmaceutical Group
Zhejiang Medicine Company